Allogeneic stem cell transplantation
โน๏ธ About
- ๐งฌ Allogeneic stem cell transplantation = transfer of haematopoietic stem cells from a healthy donor to a patient
- โก Usually performed after high-intensity chemotherapy and/or radiotherapy to eradicate malignant cells and suppress the patientโs immune system
- ๐จโ๐ฉโ๐ง Donors may be related (sibling) or unrelated volunteers
- ๐งช Requires HLA matching for best outcome
๐ฑ The Graft
- ๐ฉธ Contains stem cells that are free of malignant cells
- ๐ก๏ธ Also includes immune effector cells โ T lymphocytes and NK cells
โ๏ธ Graft Versus Malignancy Effect
- ๐ฅ Donor immune cells can attack residual malignant cells โ graft-versus-leukaemia (GVL) or graft-versus-tumour (GVT) effect
- ๐๏ธ This immune response reduces relapse risk and improves long-term survival
- ๐ก Important advantage of allogeneic over autologous transplantation
โ ๏ธ Graft Versus Host Disease (GVHD)
- ๐จ Donor lymphocytes may attack recipient tissues โ skin, liver, gut most commonly affected
- ๐ GVHD risk increases with HLA mismatch between donor and recipient
- ๐งฌ Key HLA genes: chromosome 6 loci including HLA-DR, HLA-DP, HLA-DQ
- ๐จโ๐ฉ Sibling HLA match probability โ 25% (1 in 4); chance rises with larger family size
- ๐ If no matched sibling: options include HLA-matched unrelated volunteer, partially matched haploidentical relative, or cord blood stem cells
๐ Exam Pearl: Allogeneic transplant provides a curative option in some haematological malignancies due to the GVL effect, but success is balanced by the risk of GVHD.